We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BATA:PSXBata Pakistan Limited Analysis

Data as of 2026-08-01 - not real-time

₹696.15

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Bata India’s share price is trading just below its 20‑day and 50‑day simple moving averages, confirming a short‑term bearish bias despite a bullish MACD histogram and a neutral RSI that suggests limited upside momentum. Volatility remains elevated at roughly 24% over the past month, while the stock’s beta is exceptionally low, indicating limited correlation with broader market moves. The company’s valuation appears stretched, with a price‑to‑earnings multiple well above 60 and a DCF‑derived fair value considerably lower than the current market price. Fundamentally, revenue is growing modestly, margins are respectable, and free cash flow is healthy, yet the balance sheet is burdened by a debt‑to‑equity ratio approaching 87%, raising concerns about leverage sustainability. The dividend payout sits near 86% of earnings, which, combined with the high debt load, questions the long‑term durability of the yield. Overall, the stock sits at a crossroads where technical signals are mixed, valuation is premium, and financial risk is notable.
Looking ahead, the forward earnings outlook shows a substantial uplift, hinting at potential earnings acceleration that could justify a higher multiple if growth materializes. However, the immediate upside is limited by the proximity to a key support level and the prevailing overvalued pricing. The dividend remains attractive in a low‑interest‑rate environment, but its sustainability hinges on the company’s ability to manage debt and maintain cash generation. Investors should weigh the strong brand and cash flow against the elevated valuation and leverage when forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish price trend relative to moving averages
  • Proximity to technical support level
  • High valuation relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong forward earnings growth projection
  • Robust free cash flow generation
  • Attractive dividend yield despite leverage

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Established brand and distribution network
  • Persistent high debt levels
  • Potential for earnings multiple compression if growth stalls

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin3.82%
P/E Ratio66.7
ROE8.47%
ROA5.22%
Debt/Equity86.90
P/B Ratio5.6
Op. Cash Flow₹5.9B
Free Cash Flow₹4.4B

Technical Analysis

TrendBearish
RSI51.3
Support₹664.90
Resistance₹717.50
MA 20₹689.32
MA 50₹690.37
MA 200₹821.61
MACDBullish
VolumeStable
Fear & Greed Index92.88

Valuation

Fair Value₹481.58
Target Price₹724.69
Upside/Downside4.10%
GradeOvervalued
TypeBlend
Dividend Yield1.29%

Risk Assessment

Beta0.19
Volatility23.76%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.